Unknown

Dataset Information

0

Tamoxifen Treatment of Breast Cancer Cells: Impact on Hedgehog/GLI1 Signaling.


ABSTRACT: The selective estrogen receptor (ER) modulator tamoxifen (TAM) has become the standard therapy for the treatment of ER+ breast cancer patients. Despite the obvious benefits of TAM, a proportion of patients acquire resistance to treatment, and this is a significant clinical problem. Consequently, the identification of possible mechanisms involved in TAM-resistance should help the development of new therapeutic targets. In this study, we present in vitro data using a panel of different breast cancer cell lines and demonstrate the modulatory effect of TAM on cellular proliferation and expression of Hedgehog signaling components, including the terminal effector of the pathway, the transcription factor GLI1. A variable pattern of expression following TAM administration was observed, reflecting the distinctive properties of the ER+ and ER- cell lines analyzed. Remarkably, the TAM-induced increase in the proliferation of the ER+ ZR-75-1 and BT474 cells parallels a sustained upregulation of GLI1 expression and its translocation to the nucleus. These findings, implicating a TAM-GLI1 signaling cross-talk, could ultimately be exploited not only as a means for novel prognostication markers but also in efforts to effectively target breast cancer subtypes.

SUBMITTER: Villegas VE 

PROVIDER: S-EPMC4813171 | biostudies-literature | 2016 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Tamoxifen Treatment of Breast Cancer Cells: Impact on Hedgehog/GLI1 Signaling.

Villegas Victoria E VE   Rondón-Lagos Milena M   Annaratone Laura L   Castellano Isabella I   Grismaldo Adriana A   Sapino Anna A   Zaphiropoulos Peter G PG  

International journal of molecular sciences 20160227 3


The selective estrogen receptor (ER) modulator tamoxifen (TAM) has become the standard therapy for the treatment of ER+ breast cancer patients. Despite the obvious benefits of TAM, a proportion of patients acquire resistance to treatment, and this is a significant clinical problem. Consequently, the identification of possible mechanisms involved in TAM-resistance should help the development of new therapeutic targets. In this study, we present in vitro data using a panel of different breast canc  ...[more]

Similar Datasets

| S-EPMC5574045 | biostudies-literature
| S-EPMC3416762 | biostudies-literature
| S-EPMC3837449 | biostudies-literature
| S-EPMC4741792 | biostudies-literature
| S-EPMC1855204 | biostudies-literature
| S-EPMC3058990 | biostudies-literature
| S-EPMC4028077 | biostudies-literature
| S-EPMC4264763 | biostudies-literature
| S-EPMC5801258 | biostudies-literature
| S-EPMC2656180 | biostudies-literature